The medullary thyroid cancer drugs market is estimated to be valued at USD 172.9 Mn in 2025 and is expected to reach USD 354.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032. https://justpaste.me/Q2vN5